SLN and NLC for topical, dermal, and transdermal drug delivery (2020)
Source: Expert Opinion on Drug Delivery. Unidade: FCFRP
Subjects: NANOPARTÍCULAS, LIPÍDEOS, PELE, SURFACTANTES
ABNT
SOUTO, Eliana B. et al. SLN and NLC for topical, dermal, and transdermal drug delivery. Expert Opinion on Drug Delivery, v. 17, n. 3, p. 357-377, 2020Tradução . . Disponível em: https://doi.org/10.1080/17425247.2020.1727883. Acesso em: 17 nov. 2024.APA
Souto, E. B., Baldim, I., Oliveira, W. P. de, Rao, R., Yadav, N., Gama, F. M., & Mahant, S. (2020). SLN and NLC for topical, dermal, and transdermal drug delivery. Expert Opinion on Drug Delivery, 17( 3), 357-377. doi:10.1080/17425247.2020.1727883NLM
Souto EB, Baldim I, Oliveira WP de, Rao R, Yadav N, Gama FM, Mahant S. SLN and NLC for topical, dermal, and transdermal drug delivery [Internet]. Expert Opinion on Drug Delivery. 2020 ; 17( 3): 357-377.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1080/17425247.2020.1727883Vancouver
Souto EB, Baldim I, Oliveira WP de, Rao R, Yadav N, Gama FM, Mahant S. SLN and NLC for topical, dermal, and transdermal drug delivery [Internet]. Expert Opinion on Drug Delivery. 2020 ; 17( 3): 357-377.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1080/17425247.2020.1727883